Are you currently undergoing breast cancer treatment? A new study is looking for survivors who are taking either Afinitor Tykerb. Researchers want to learn more about the patient experience including daily nutrition and any side effects they may be noticing. Want to learn more?
GlaxoSmithKline’s Focus on the Patient team is conducting this study of oncology patients. To be eligible, you must be:
• Currently taking one of these medications – Afinitor or Tykerb – as part of treatment regimen for at least the past two months
• Available to participate in on-on-one interviews on one of the following dates: May 19, 20 or 21 to be conducted in Collegeville, PA or via Skype or telephone.
• Willing to discuss daily nutrition and any side effects experienced as a result of this treatment as well as its effects on quality of life
Researchers are hoping to gain insight into any changes for patients related to the treatment. If you are interested in volunteering for this study, please contact Kay Warner at email@example.com or call the PBCC at 800-377-8828.